Mantle Cell Lymphoma Treatment

Mantle Cell Lymphoma Treatment

Mantle Cell Lymphoma Treatment is difficult because cases are typically diagnosed in advanced stages when the disease has metastasized to other parts of the body. Mantle cell lymphoma entails the irregular growth of immune cells often known as B cells, and may have an effect on lymph nodes, the spleen, blood, bone marrow, and other tissues.

How Is Mantle Cell Lymphoma Treatment? Since mantle cell lymphoma has often spread throughout your body by the point it is identified, it can be onerous to treatment. Even though it tends to grow slower than some lymphomas, it often would not respond as well to therapy, or sometimes the lymphoma has a recurrence. Although typically it cannot be cured in advanced stages, therapies and treatment can help you live longer and maintain a higher quality of life.

Low-grade lymphomas are often called "indolent" lymphomas since they sometimes develop comparatively slowly and should have few apparent symptoms. In addition, in some instances, indolent lymphomas could progressively transform into a mix of indolent and aggressive lymphoma, requiring extra aggressive treatment approaches. Evidence signifies that, though indolent lymphomas are not often fully "cured," affected individuals may have the disease over long periods with a comparatively good high quality of life.

What are the Symptoms of Mantle Cell Lymphoma?

Mantle Cell Lymphoma accounts for 2%-10% of all Non-Hodgkin Lymphoma cases. Symptoms for Mantle Cell Lymphoma can be different for each case but typically include:

  • Swollen lymph nodes in the armpit, neck, or groin
  • Night sweats
  • Fever and Fatigue
  • Shortness of breath and coughing
  • Pain or swelling behind the abdomen wall

Such findings may be because of enlargement of stomach lymph nodes, the spleen, or liver. Symptoms are typically not experienced until later stages.

What are Mantle Cell Lymphoma Treatment?

The recommended treatment methods depend on the stage of the disease and the patient’s overall health. Because most MCL patients are diagnosed in advanced stages, there is not a wide variety of treatment plans. MCL Treatments include:

  • Active Surveillance: For patients with an indolent case of MCL, the physician will monitor them and their symptoms closely. However, most patients will require treatment.
  • Combination Therapy: Most often, patients are treated with a combination of chemotherapy and Rituximab. Other combinations of drugs can be used. Combination therapy can be more intense and cause increased side effects, so it is generally used on younger patients or those with good overall health.
  • Radiation Therapy: For early stage patients, radiation therapy can be used or combined with other drug therapies. Since not many patients are diagnosed in early stages, the treatment will be decided based on the individual.
  • CAR T-Cell Therapy: For those with relapsed or refractory MCL, a majority of patients respond to Car T-Cell therapy, which uses the patient’s immune cells (T cells) to recognize and kill cancer cells within the body.
  • Autologous Stem Cell Transplantation (ASCT): Stem cells are collected before chemotherapy from the bone marrow and are stored. Typically used after combination therapy to restore bone marrow cell production.
  • Clinical Trials: Clinical trials work to improve on current treatment methods and test the feasibility of new drugs. Clinical researchers are investigating acceptable methods in which to mix various therapies and to cut back potential unwanted effects. Such analysis may also reveal completely different patterns of malignant cell distribution.

Hodgkin’s Disease and non-Hodgkin’s Lymphoma

Testing is necessary to substantiate the precise kind of Non-Hodgkin’s Lymphoma (NHL) present, to evaluate the nature and extent of the disease, and to determine the most acceptable therapies. Hodgkin’s disease and non-Hodgkin’s lymphoma are the two main types of cancers affecting the lymphatic system. In contrast to NHL, Hodgkin’s disease is typically characterized by the presence of a specific sort of cancer cell known as a Reed-Sternberg cell that has more than one nucleus. A hematologist-oncologist is an expert in treating blood cancers, including mantle cell lymphoma. Because it is an uncommon disease, many oncologists might not have experience treating it.

The continuous improvement of accessible therapy options signifies that medical doctors might be able to treat stage 4 lymphoma, depending on the type and a person’s individual factors. If remission is not obtainable, treatment handles a patient’s symptoms and aims to maintain their quality of life. There are nearly 200 active clinical trials for Mantle Cell Lymphoma patients, learn more about the benefits they can provide you.

By Cancer Clinical Trial Specialist Mantle Cell Lymphoma Blog 0 Comments


Your email address will not be published. Required fields are marked *